A pivotal registration study of Epitinib in subjects with non-small cell lung cancer with brain metastasis.
Phase of Trial: Phase III
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Epitinib (Primary)
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Jul 2017 According to Chi-Med media release, company plans to initiate Phase III registration study in China in late 2017 or early 2018
- 29 Aug 2016 New trial record
- 02 Aug 2016 According to Chi-Med media release, company targets to initiate pivotal registration study in H1 2017.